Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2025Medical Journal of BabylonOpen Access

Assessment of Apo Lipoprotein A-I and High-Density Lipoprotein Levels in Patients with Prostate Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

HDHussein Bahaa DeaibilAAArshad Noori Al-DujailiHSHayder Jaber Sagban

Discussion

Loading...

Member takes

Overview

Analysis reveals decreased ApoA-I and HDL levels in men with prostate cancer, suggesting their role in cancer progression.

Key Points

  • Prostate cancer patients showed significantly lower ApoA-I and HDL levels compared to benign conditions and controls.
  • ApoA-I and HDL levels were markedly reduced in newly diagnosed and tumor-treated patients at grade IV versus lower grades.
  • This study assessed ApoA-I and HDL levels in 180 male patients, divided into four distinct groups based on prostate conditions.
  • Findings indicate the potential of using low levels of ApoA-I and HDL as markers for early prostate cancer detection.

Cite This Study

Deaibil et al. (2025) studied this question.

synapsesocial.com/papers/68dd91dafe798ba2fc499525https://doi.org/10.4103/mjbl.mjbl_272_23
View Full Paper
Ask AI
Bookmark
Share